UnitedHealth Group stock ends the day little changed at the close
Published on 09/21/2026 at 22:35 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
UnitedHealth Group stock closed at USD 377.56 on the NYSE on September 21, 2026, a gain of 0.18 percent versus the prior close of USD 376.90. Compared with the broader market, the stock’s modest advance contrasted with a 0.38 percent decline in the S&P 500, which finished at 7,718.60 per NYSE data from Yahoo Finance.
September 21, 2026 in numbers
UnitedHealth Group Inc. (ISIN US91324P1021, NYSE: UNH) opened the regular session at USD 377.87, traded as high as USD 378.95 and as low as USD 373.82, and closed back near the opening level at USD 377.56. Historical data from Yahoo Finance showed volume of about 4.61 million shares, somewhat below the average of around 5.35 million shares reported on the main quote page. The same overview placed the stock’s 52-week range between USD 255.97 and USD 461.62, so today’s close left the shares well below their recent high.
Sector context remained mixed. A peer such as Elevance Health closed lower on the day, while UnitedHealth held a small gain, underscoring the stock’s relative resilience within the managed-care group, according to healthcare plans comparisons at Yahoo Finance. Broader reports on Wall Street’s move higher for some technology names noted that UnitedHealth’s shares slipped in earlier trading before recovering toward the close, per a market roundup from The Moscow Times.
After the bell today and next steps
In after-hours trading the shares last changed hands modestly above the regular-session close, around USD 377.90 at 4:34 p.m. ET, per extended-hours data on Yahoo Finance. Looking ahead, UnitedHealth’s next quarterly earnings report is scheduled for October 13, 2026, as indicated by the earnings calendar referenced by MarketBeat, and analysts there highlighted optimistic profit expectations heading into that date. On the next trading day, September 22, 2026, investors will continue to weigh sector dynamics and the broader S&P 500 path as they position around the stock’s upcoming earnings event, with rate-sensitive and healthcare names remaining tied to macro data and policy signals.
